![Leonard Schleifer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leonard Schleifer
Chief Executive Officer at REGENERON PHARMACEUTICALS, INC.
Net worth: 2 348 M $ as of 2024-05-30
Profile
Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-06-11 | 1,725,565 ( 82.56% ) | 1 691 M $ | 2024-05-30 | |
2024-06-11 | 670,346 ( 0.62% ) | 657 M $ | 2024-05-30 |
Leonard Schleifer active positions
Companies | Position | Start |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Chief Executive Officer | 1988-01-07 |
Regeneron Ireland DAC
![]() Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Chief Executive Officer | 2012-12-31 |
Former positions of Leonard Schleifer
Companies | Position | End |
---|---|---|
Weill Cornell Medical College | Corporate Officer/Principal | - |
Training of Leonard Schleifer
University of Virginia | Doctorate Degree |
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REGENERON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Regeneron Ireland DAC
![]() Regeneron Ireland DAC BiotechnologyHealth Technology Part of Regeneron Pharmaceuticals, Inc., Regeneron Ireland DAC is a leading Irish biotechnology company that uses science to develop new medicines for patients. The company is located in Ireland. The company successfully manufactures a range of biopharmaceuticals for patients worldwide, including approved therapeutic proteins and those involved in clinical studies. | Health Technology |
- Stock Market
- Insiders
- Leonard Schleifer